Evotec
About Us
Careers
News
Resources
Blog
Events
Contact Us
Drug Design and Discovery
Integrated Discovery
Capabilities
Therapeutic Areas
IND Enabling
Integrated Development
Capabilities
Integrated CMC
Integrated Development
Capabilities
INDiGO®
Evotec
Evotec and Celgene expand IPSC collaboration to include additional cell lines
by
Nerina Coppini
on May 29, 2018 7:00:00 PM
Tweet
$ 6 M payment to access additional cell lines
Topics:
Corporate
,
Celgene
,
IPSC
,
Evotec
Read More
Most Read
Posts by Topic
Corporate
(35)
Business
(14)
Drug Discovery
(12)
Drug Development
(9)
Drug design and discovery
(9)
Partner Research Organization
(8)
Evotec
(7)
Strategy
(5)
Antibiotic Resistance
(4)
New appointments
(4)
Sanofi
(4)
Acquisition
(3)
INDiGO
(3)
Bayer
(2)
CMC
(2)
Celgene
(2)
Contract Reseach Organization
(2)
Endometriosis
(2)
Gram-negative bacteria
(2)
Integrated CMC
(2)
infectious diseases
(2)
2018 results
(1)
Active Pharmaceutical Ingredient
(1)
Antibacterial
(1)
Apeiron
(1)
Aptuit
(1)
Arix Bioscience
(1)
Assay Development
(1)
Blood cancer
(1)
CMO award
(1)
Carna Biosciences
(1)
Chronic cough
(1)
Compound Logistics
(1)
Computational Chemistry
(1)
Dementia Drug Discovery
(1)
Finance
(1)
Form selection
(1)
Fred Hutchinson Cancer Research Center
(1)
Hit Discovery
(1)
IND Enabling
(1)
IPSC
(1)
Investments
(1)
Material Sciences
(1)
Oncology
(1)
Phase I
(1)
Regulatory
(1)
Research collaboration
(1)
Respiratory
(1)
Retinal diseases
(1)
TARGETBCD
(1)
beta cell replacement
(1)
crispr
(1)
diabetes
(1)
first quarter update
(1)
genomics
(1)
immuno-oncology
(1)
microRNA
(1)
pre-clinical development
(1)
technology
(1)
